| 12429486 |
Use of Tenascin-C as an extracellular marker of tumor-derived microparticles |
Steven Gareth Griffiths |
2025-09-30 |
|
| 11835530 |
Detection of microparticle-associated proteins associated with spontaneous preterm birth |
Brian D. BROHMAN |
2023-12-05 |
|
| 11513125 |
Microvesicle histone H2AX as a biomarker for genotoxic stress |
— |
2022-11-29 |
|
| 11307204 |
5-ALA for detection of brain tumors |
— |
2022-04-19 |
|
| 10928402 |
Treatment of spontaneous preterm birth |
Brian D. BROHMAN |
2021-02-23 |
|
| 10877046 |
Treatment of spontaneous preterm birth |
Brian D. BROHMAN, Zhen Zhang, Kevin S. GOUDY, Robert C. Doss, Kevin P. Rosenblatt |
2020-12-29 |
|
| 9493810 |
5-ALA for detection of brain tumors |
— |
2016-11-15 |
|
| 8207219 |
Ion channel modulating activity I |
David Fedida, Gregory N. Beatch, Peter Orth, Christian Hesketh |
2012-06-26 |
$530,000 |
| 8188140 |
Uses of ion channel modulating compounds |
Gregory N. Beatch |
2012-05-29 |
$508,000 |
| 7820712 |
Uses of ion channel modulating compounds |
Gregory N. Beatch |
2010-10-26 |
$3,281,000 |
| 7786119 |
Drug conjugates of ion channel modulating compounds |
Elizabeth L. S. Cheu, Lewis Siu Leung Choi, Doug Ta Hung Chou, Allen Davidoff, Grace Jung +2 more |
2010-08-31 |
$4,047,000 |
| 7674820 |
Ion channel modulating activity I |
David Fedida, Gregory N. Beatch, Peter Orth, Christian Hesketh |
2010-03-09 |
$5,232,000 |
| 7507545 |
Ion channel modulating activity method |
David Fedida, Gregory N. Beatch, Peter Orth |
2009-03-24 |
$3,640,000 |
| 7345086 |
Uses of ion channel modulating compounds |
Gregory N. Beatch |
2008-03-18 |
$3,508,000 |
| 7256253 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
Dominique P. Bridon, Peter G. Milner, Darren L. Holmes, Karen Thibaudeau |
2007-08-14 |
|
| 6887849 |
Long lasting synthetic glucagon-like peptide {GLP-1} |
Dominique P. Bridon, Benoit L'Archeveque, Darren L. Holmes, Anouk Leblanc, Serge St. Pierre |
2005-05-03 |
|
| 6887470 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
Dominique P. Bridon, Peter G. Milner, Darren L. Holmes, Karen Thibaudeau |
2005-05-03 |
|
| 6849714 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
Dominique P. Bridon, Peter G. Milner, Darren L. Holmes, Karen Thibaudeau |
2005-02-01 |
|
| 6821949 |
Long lasting synthetic glucagon-like peptide (GLP-1) |
Dominique P. Bridon, Benoit L'Archeveque, Darren L. Holmes, Anouk Leblanc, Serge St. Pierre |
2004-11-23 |
|
| 6706892 |
Pulmonary delivery for bioconjugation |
Angelica Fleser, Martin Robitaille, Peter G. Milner, Dominique P. Bridon |
2004-03-16 |
|
| 6610825 |
Method for alleviating pain or providing an analgesic effect in a patient |
Dominique P. Bridon, Darren L. Holmes, Peter G. Milner |
2003-08-26 |
|
| 6602981 |
Antinociceptive agent derivative |
Dominique P. Bridon, Darren L. Holmes, Peter G. Milner |
2003-08-05 |
|
| 6593295 |
Long lasting insulinotropic peptides |
Dominique P. Bridon, Benoit L'Archeveque, Darren L. Holmes, Anouk Leblanc, Serge St. Pierre |
2003-07-15 |
|
| 6514500 |
Long lasting synthetic glucagon like peptide {GLP-!} |
Dominique P. Bridon, Benoit L'Archeveque, Darren L. Holmes, Anouk Leblanc, Serge St. Pierre |
2003-02-04 |
|
| 6500918 |
Conjugate comprising an antinociceptive agent covalently bonded to a blood component |
Dominique P. Bridon, Darren L. Holmes, Peter G. Milner |
2002-12-31 |
|